Jonathan Stokke Coachlife A new oral GLP 1 medication has just launched in the United States. For many patients, this represents another important step forward in the treatment of obesity and metabolic disease. Unlike the injectable Benefit Risk Assessment of GLP 1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy Springer Nature Link Allison Stokke from pole vault sensation to golfer's wife and mom